Skip to main content
Industry · Scientific research and development

Research and experimental development on natural sciences and engineering.

Companies and filings in the Research and experimental development on natural sciences and engineering industry, within the Professional, scientific and technical activities sector.

628 Companies
20 New filings

Latest filings

Live feed
Company Document Date Actions
Regulatory Filings
Sino Biological's Cell-Free Protein Synthesis Supports Tencent AI for Life Sciences Lab's Protein Design Study Published in Nature Communications
May 28
Regulatory Filings
Launch of brain health study with Oura
May 28
Share Issue/Capital Change
PREDICT: AVVENUTO DEPOSITO DELLO STATUTO AGGIORNATO A SEGUITO DELLA VARIAZIONE DELLA COMPOSIZIONE DEL CAPITALE SOCIALE POST-ANNULLAMENTO DELLA SECONDA TRANCHE DI PAS
May 28
Declaration of Voting Results & Voting Rights Announcements
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 28, 2026
May 28
Annual Report
Annual Report and Accounts to 31 December 2025
May 28
Transaction in Own Shares
Next Day Disclosure Return - Changes in issued shares and share buybacks
May 28
Board/Management Information
第六届董事会第十八次会议决议公告
May 28
Declaration of Voting Results & Voting Rights Announcements
2025年年度股东会决议公告
May 28
Share Issue/Capital Change
关于向激励对象预留授予限制性股票的公告
May 28
Regulatory Filings
北京市竞天公诚律师事务所上海分所关于睿智医药科技股份有限公司2025年限制性股票激励计划预留授予事项之法律意见书
May 28
Share Issue/Capital Change
董事会薪酬与考核委员会关于公司2025年限制性股票激励计划预留授予激励对象名单(授予日)的核查意见
May 28
Regulatory Filings
2025年年度股东会法律意见书
May 28
Share Issue/Capital Change
2025年限制性股票激励计划预留授予激励对象名单(授予日)
May 28
Regulatory Filings
Dokonanie odpisu aktualizującego wycenę kontraktu długoterminowego. - Content (PL)
May 28
Regulatory Filings
Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
May 28
Transaction in Own Shares
Next Day Disclosure Return
May 28
Regulatory Filings
INSIDE INFORMATION ANNOUNCEMENT VISEPEGENATIDE INJECTION INCLUDED IN THE PUBLICATION OF SUPPLEMENTAL DRUG INFORMATION FOR THE SECOND BATCH OF REFERENCE DRUG PRE-COMMUNICATION IN 2026
May 28
Proxy Solicitation & Information Statement
PROXY FORM
May 28
Proxy Solicitation & Information Statement
NOTICE OF ANNUAL GENERAL MEETING
May 28
Proxy Solicitation & Information Statement
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND BUY BACK SHARES, PROPOSED RE-ELECTION OF DIRECTORS, PROPOSED RE-APPOINTMENT OF AUDITOR, PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF
May 28

Companies in this industry

Company Country Market cap
1NKEMIA
IKM
Biotechnology company providing R&D and services for the life sciences sector.
Spain
2cureX AB
2CUREX $5.24M
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden $5.24M
Abattis Bioceuticals Corp.
ATTBF
Life sciences company aggregating and investing in cannabis technologies and health solutions.
Canada
Abera Bioscience AB
ABERA
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABION Inc.
203400
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
ABL Bio Inc.
298380
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
Abnova
4133 $40.26M
Global leader in high-throughput production of antibodies and recombinant proteins.
Taiwan $40.26M
Abpro Holdings, Inc.
ABP $1.42M
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America $1.42M
Absci Corp
ABSI $762.38M
A generative AI drug creation company developing biologic medicines.
United States of America $762.38M
Achiko AG
ACHI
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACROBIOSYSTEMS CO.,LTD.
301080
Provides recombinant proteins and reagents for life sciences and drug development.
China
ACTINOGEN MEDICAL LIMITED
ACW
Developing cortisol-inhibiting therapies for Alzheimer's and cognitive impairment.
Australia
Active Biotech
ACTI $19.24M
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden $19.24M
Adagene Inc.
ADAG $188.05M
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
Cayman Islands $188.05M
ADALTA LIMITED
1AD
Clinical-stage biotech developing i-body protein therapeutics for fibrotic diseases.
Australia
Adaptive Biotechnologies Corp
ADPT $2.22B
Decodes the adaptive immune system to develop products for diagnosing and treating disease.
United States of America $2.22B
Adeia Inc.
ADEA $2.91B
R&D company that licenses IP for the media, entertainment, and semiconductor industries.
United States of America $2.91B
Aditxt, Inc.
ADTX $47k
Acquires, develops, and deploys health technologies to address major health challenges.
United States of America $47k
Advanced Biomed Inc.
ADVB $6.51M
Develops microfluidic biochip diagnostic systems for precision oncology.
United States of America $6.51M
Advanced Proteome Therapeutics Corporation
APC.H
Develops proprietary technology for chemical modification of proteins to create anti-cancer ADCs.
Canada
AIM ImmunoTech Inc.
AIM $2.32M
Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.
United States of America $2.32M
Ainos, Inc.
AIMD $10.75M
Develops AI-driven diagnostics, immune therapeutics, and telehealth POCT devices.
United States of America $10.75M
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, prioritizing contract services.
Canada
Akero Therapeutics, Inc.
AKRO $4.50B
Clinical-stage company developing treatments for serious metabolic diseases like MASH.
United States of America $4.50B
Aladdin Healthcare Technologies SE
NMI
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
Germany
Alamar Biosciences, Inc.
ALMR
Powering precision proteomics for earliest disease detection with ultra-high sensitivity platform.
United States of America
Alaunos Therapeutics, Inc.
TCRT $5.73M
Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.
United States of America $5.73M
ALGORAE PHARMACEUTICALS LIMITED
1AI
Biopharmaceutical firm using AI to develop neurodegenerative disease treatments.
Australia
Aligos Therapeutics, Inc.
ALGS $42.51M
A clinical-stage biopharmaceutical company developing therapeutics for liver and viral diseases.
United States of America $42.51M
Allelix Biopharmaceuticals Inc.
ALX
Biopharmaceutical R&D focused on protein-based drugs and neuroscience therapeutics.
Canada
Alpha Tau Medical Ltd.
DRTS $916.18M
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America $916.18M
Alteogen Inc.
196170
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
ALTERITY THERAPEUTICS LIMITED
ATH
Clinical-stage developer of disease-modifying therapies for neurodegenerative disorders.
Australia
AlzeCure Pharma
ALZCUR $21.28M
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden $21.28M
AMPLIA THERAPEUTICS LIMITED
ATX
Clinical-stage developer of FAK inhibitors for solid tumors and fibrotic diseases.
Australia
ANAPTYSBIO, INC
ANAB $1.76B
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America $1.76B
ANATARA LIFESCIENCES LTD
ANR
Develops non-antibiotic gastrointestinal health solutions for humans and animals.
Australia
AngioLab, Inc.
251280
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
Anhui Wanbang Pharmaceutical Technology Co.,Ltd.
301520
Pharmaceutical CRO specializing in clinical trials, BE studies, and drug development.
China
Anixa Biosciences Inc
ANIX $91.53M
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America $91.53M
Annovis Bio, Inc.
ANVS $91.47M
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America $91.47M
AnorMED Inc.
Developed small molecule therapeutics for serious diseases, including cancer and HIV.
Canada
ANTEOTECH LTD
ADO
Develops nanoglue technology for life sciences and lithium-ion battery applications.
Australia
Anthem Biosciences Limited
ANTHEM
Integrated CRAMS organization for drug discovery, development, and manufacturing.
India
APPLIED DNA SCIENCES INC
APDN $7.26M
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America $7.26M
Aprea Therapeutics, Inc.
APRE $7.82M
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America $7.82M
AprilBio Co.,Ltd.
397030
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
Aptahem AB
APTA
A clinical-stage biotech developing aptamer-based drugs for life-threatening conditions.
Sweden
APTAMER GROUP PLC
APTA $27.66M
Develops custom affinity binders for research, diagnostics, and therapeutics.
United Kingdom $27.66M
Aptevo Therapeutics Inc.
APVO $5.73M
Clinical-stage biotech developing antibody-based immunotherapies for cancer.
United States of America $5.73M